FDA — authorised 5 July 1967
- Marketing authorisation holder: CNTY LINE PHARMS
- Status: approved
🇺🇸 Hiprex in United States
FDA authorised Hiprex on 5 July 1967
Marketing authorisation
Hiprex in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Infectious Disease approved in United States
Frequently asked questions
Is Hiprex approved in United States?
Yes. FDA authorised it on 5 July 1967.
Who is the marketing authorisation holder for Hiprex in United States?
CNTY LINE PHARMS holds the US marketing authorisation.